TREA

85261936 - JOVOLA

Follow

Information

  • Trademark
  • 85261936
  • Serial Number
    85261936
  • Registration Number
    4651130
  • Filing Date
    March 09, 2011
    13 years ago
  • Registration Date
    December 09, 2014
    10 years ago
  • Transaction Date
    August 24, 2021
    3 years ago
  • Status Date
    July 16, 2021
    3 years ago
  • Published for Opposition Date
    September 23, 2014
    10 years ago
  • Location Date
    December 09, 2014
    10 years ago
Information
Mark Drawing Code
4000
Mark Identification
JOVOLA
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of amyotropic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Alzheimer's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; pharmaceutical preparations and substances for the prevention, treatment and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of cardio-pulmonary disorders, diseases, conditions, and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension, high blood pressure, heart filure and ventricular dysfunction; pharmaceutical preparations and substances for the prevention, treatment and alleviation of metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of viral and infectious diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, cerebral palsy, insomnia, mood disorders, bipolar disorder, seizure disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations for the treatment of immunologic diseases, namely, auto immune motility diseases, immunologic deficiency syndromes, auto immune diseases, Acquired Immune Deficiency Syndrome (AIDS), hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
Case File Event Statements
  • 7/16/2021 - 3 years ago
    55 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 5/3/2020 - 4 years ago
    54 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 5/3/2020 - 4 years ago
    53 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/3/2020 - 4 years ago
    52 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/3/2020 - 4 years ago
    51 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/3/2020 - 4 years ago
    50 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 12/9/2019 - 5 years ago
    49 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 7/10/2019 - 5 years ago
    48 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 3/20/2019 - 5 years ago
    47 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/16/2018 - 6 years ago
    46 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/16/2018 - 6 years ago
    45 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/21/2018 - 6 years ago
    44 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 1/11/2017 - 7 years ago
    43 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 3/3/2016 - 8 years ago
    42 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/21/2015 - 9 years ago
    41 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 12/9/2014 - 10 years ago
    40 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/23/2014 - 10 years ago
    39 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/23/2014 - 10 years ago
    38 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/3/2014 - 10 years ago
    37 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/19/2014 - 10 years ago
    36 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/18/2014 - 10 years ago
    35 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/30/2014 - 10 years ago
    34 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/30/2014 - 10 years ago
    33 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/30/2014 - 10 years ago
    32 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/14/2014 - 10 years ago
    31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/14/2014 - 10 years ago
    30 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/14/2014 - 10 years ago
    29 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/22/2014 - 10 years ago
    28 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/22/2014 - 10 years ago
    27 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/15/2014 - 10 years ago
    26 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 7/13/2013 - 11 years ago
    25 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 1/9/2013 - 11 years ago
    24 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 8/1/2012 - 12 years ago
    23 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 7/6/2012 - 12 years ago
    22 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 7/6/2012 - 12 years ago
    21 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 7/6/2012 - 12 years ago
    20 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 6/27/2012 - 12 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/26/2012 - 12 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/26/2012 - 12 years ago
    17 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 6/27/2012 - 12 years ago
    16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 6/27/2012 - 12 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 12/15/2011 - 13 years ago
    14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/15/2011 - 13 years ago
    13 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/15/2011 - 13 years ago
    12 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/15/2011 - 13 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/15/2011 - 13 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/15/2011 - 13 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 12/9/2011 - 13 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/9/2011 - 13 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/9/2011 - 13 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/9/2011 - 13 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/9/2011 - 13 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/6/2011 - 13 years ago
    3 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 3/14/2011 - 13 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/12/2011 - 13 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP